Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs work by mimicking the natural actions of GLP-1, a hormone produced by the gut in https://thegreatbookmark.com/story20810558/reta-glucagon-like-peptide-1-receptor-agonists